A novel oral colon-specific drug delivery system (CDDS) has been developed as one of the site-specific drug delivery systems. This delivery system, by means of combining one or more controlled release mechanisms, hardly releases the drug in the upper part of the gastrointestinal (GI) tract, but rapidly releases drug in the colon following oral administration. The necessity and advantage of CDDS have been recognized and reviewed recently (1-3). Owing to CDDS specifically delivering the drug to the colon, many bene- The aim of this study was to investigate the combined influence of 3 independent variables in the compression coated tablet of mesalamine for ulcerative colitis. A 3--factor, 3-level Box-Behnken design was used to derive a second order polynomial equation and construct contour plots to predict responses. The independent variables selected were: percentage of polymers (pectin and compritol ATO 888) in compression coating (X 1 ), coating mass (X 2 ) and coating force (X 3 ). Fifteen batches were prepared and evaluated for percent of drug released in 5 h (Y 5 ), time required for 50 % mesalamine to dissolve (t 50 ) with rat cecal (RC) content and without rat cecal content (t 50 ), percent of drug released in 24 h in the presence of rat cecal content (Y 24 with RC). Transformed values of independent and dependent variables were subjected to multiple regressions to establish a full-model second-order polynomial equation. F was calculated to confirm the omission of insignificant terms from the full-model equation. The computer optimization process and contour plots predicted the levels of independent variables X 1 , X 2 , and X 3 (0, 0.2 and -0.15, respectively) for colon targeting and total percent of drug released up to 24 h.
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Methods
Preparation of 5-ASA core tablets. -Mesalamine was dry mixed with polyvinyl pyrollidone K-30 (PVP K-30) and water was added to granulate. Wet granules were sieved through a 1-mm screen and dried overnight at 40°C. After adding 0.25 % magnesium stearate as a lubricant, tablets containing 100 mg of the drug were compressed using a Cadmach single punch tablet machine (M/S. Cadmach Machinery Co. Pvt. Ltd, India) with 6-mm flat faced punches. Tests such as mass variation, crushing strength, friability, thickness, and dissolution were performed on the core tablets.
Box-Behnken experimental design. -A Box-Behnken statistical design with 3 factors, 3 levels, and 15 runs was selected for the optimization study (12) . The experimental design consists of a set of points lying at the midpoint of each edge and the replicated center point of a multidimensional cube. Independent and dependent variables are listed in Table I . The polynomial equation generated by this experimental design (using Sigma Plot 11) is as follows:
where Y i is the dependent variable, b 0 is the intercept, b 1 to b 33 are the regression coefficients, and X 1 , X 2 and X 3 are the independent variables selected from preliminary experiments. The experimental design is summarized in Table II . pectin/20 % compritol ATO 888 and 60 % pectin/40 % compritol ATO 888 combinations were used for the outer shell compression coating. Coating forces were 20, 30 or 40 kN, and the coat mass was 250, 350 or 450 mg. To prepare coated tablets, half of the coating material was placed in a concave die (10 mm), the core tablet was carefully positioned in the centre of the die and the remaining coat material was added. The coat was compressed around the core at different compression forces (13) . Thickness was measured with a vernier caliper (SV-03, E-Base Measuring Tools, Taiwan). The hardness and friability of the core tablets and of the compression-coated tablets were determined using a hardness tester (Monsanto Tablet Hardness Tester, Mht-20, Campbell Electronics, India) and the Roche Friabilator (Type EF2, Eletrolab, India), respectively. The mass variation test was done by weighing 20 tablets individually, calculating the average mass and comparing the individual tablet mass to the average. Dissolution rates in different media were recorded on the compression coated tablets.
In vitro drug release. -Drug release studies (n = 3) were conducted under conditions mimicking mouth-to-colon transit (14) (15) (16) . The dissolution medium consisted of 900 mL 0.1 mol L -1 HCl for 2 h, replaced by 900 mL Sorensen's phosphate buffer, pH 7.4 for 3 h, kept at 37 ± 0.5°C and stirred at 100 rpm, using a USP (17) dissolution apparatus type II (TDT-06Lplus, Electrolab, India). Samples (5 mL) were withdrawn at the end of specified periods (2 h and 5 h), filtered using membrane filters (0.45 mm) and assayed spectrophotometrically (UV-1601, Shimadzu, USA) for mesalamine at 301.5 nm in 0.1 mol L -1 HCl and at 334.5 nm in pH 7.4 buffer. To assess the susceptibility of the prepared mesalamine delivery systems to the enzymatic action of colonic bacteria, drug release studies were continued in phosphate buffer saline (PBS) pH 6.8 in the absence (control) and in the presence of rat cecal contents, since these are known to have similar contents, to those of human intestinal microflora (18). The studies were carried out using USP dissolution apparatus 1 (100 rpm, 37°C) with slight modifications. A glass beaker (250 mL) containing 100 mL PBS pH 6.8 was immersed in the flask of the dissolution apparatus with water at 37 ± 0.5°C. After completing the dissolution in 0.1 mol L -1 HCl (2 h) and phosphate buffer, pH 7.4 (3 h), baskets containing the tablets under study were immersed in the PBS medium and the release study was continued for up to 24 h. Samples (5 mL) were withdrawn at different time points (6, 8, 12 and 24 h), filtered using membrane filters (0.45 mm) and assayed spectrophotometrically for mesalamine at 299 nm in PBS pH 6.8. The same volume of fresh dissolution medium was added to restore the initial volume of the dissolution medium after each sample withdrawal. Experiments were carried out in triplicate.
Preparation of rat cecal content medium. -Before starting experiments on animals, the experimental protocol was subjected to the scrutiny of the Institutional Animal Ethical Committee (IAEC) of Anand Pharmacy College, Anand, India, and was approved. Susceptibility of the compression coated tablet to the enzymatic action of colonic bacteria was assessed by performing drug release in the medium contacting rat cecal content. Cecal material was collected from male albino rats weighing 150-200 g maintained on a normal diet, but the cecal enzyme production was induced by giving orally 1 mL of 2 % (m/V) dispersion of pectin for 7 days (administered directly into the stomach using teflon tubing). Thirty minutes before the commencement of drug release studies, four rats were killed and their abdomens were opened, the cecai was isolated, ligated at both ends, cut loose and immediately transferred into PBS previously bubbled with carbon dioxide. The cecal bags were opened and their contents were individually weighed, pooled and then suspended in PBS to give a final cecal dilution of 4 % (m/V).
The dissolution study was continued in 100 mL of the above made rat cecal media after 5 h. This was done with slight modification in the experimental set-up of the USP dissolution test apparatus. A beaker of 250 mL capacity containing 100 mL of PBS (pH 6.8) with rat cecal content was placed suitably in the dissolution vessel having water maintained at 37 ± 0.5°C, which in turn was kept in the water bath of the apparatus. The study was continued from the 6 th h to 24 th h and the samples were withdrawn at different intervals (6, 8, 12 and 24 h) for analysis and each time replaced with fresh PBS containing rat cecal material bubbled with CO 2 . The withdrawn samples were diluted with PBS and centrifuged. The supernatant was filtered through membrane filters (0.45 mm) and the filtrate was analyzed for mesalamine content 299 nm. Optimum formula. -After developing the polynomial equations for the responses Y 5 , t 50 with RC and Y 24 with RC with the independent variables, the formulation was optimized for the response Y 24 with RC. Optimization was performed to find out the level of independent variables (X 1 , X 2 , and X 3 ) that would yield a maximum value of Y 24 with RC with a minimum value of Y 5 .
RESULTS AND DISCUSSION
An attempt was made to minimize drug release in the physiological environment of the GIT and to ensure maximum drug release in the colon by applying pectin as a compression coat over the mesalamine core tablets. It was found from the in vitro dissolution study that pectin alone cannot give a hard coat, so Compritol ATO 888 was added because it retards the release until polymer solubilization takes place at the higher pH of the colon. From Table II it was found that independent variable, X 1 (percentage of polymers, in compression coating) at high level medium level of (80-20) (100-0) could the release drug into the physiological stomach and intestine environment.
Data analysis
All batches of compression coated tablets were evaluated for Y 5 , t 50 with RC and Y 24 with RC. Transformed values of all the batches, along with their results are shown in Table II . Formulations 2, 4, 5, 6, 9, 10, 13, 14 and 15 had the lowest Y 5 (0 %). Table III shows the observed and predicted values with residuals and percent error of responses for all batches. The Y 5 (dependent variable) obtained at various levels of the 3 independent variables (X 1 , X 2 , and X 3 ) was subjected to multiple regression to yield a second-order polynomial equation (full model):
The value of the coefficient of determination (R 2 ) of Eq. (2) was found to be 0.9952, indicating good fit. The Y 5 values measured for the different batches showed wide variation (i.e., values ranged from a minimum of 0 to a maximum of 30.29). The results clearly indicate that the Y 5 value is strongly affected by the variables selected for the study. This is also reflected in the wide range of values for coefficients of the terms of Eq. (2) The main effects of X 1 , X 2 , and X 3 represent the average result of changing 1 variable at a time from its low level to its high level. The interaction terms (X 1 X 2 , X 1 X 3 , X 2 X 3 , X 1 2 , X 2 2 , and X 3 2 ) show how Y 5 changes when 2 variables are simultaneously changed. The negative coefficients for 2 independent variables, X 2 and X 3 , indicate an unfavorable effect on Y 5 , while the positive coefficients for the interactions between 2 variables X 2 X 3 indicate a favorable effect on 
The value of R 2 from Eq. (4) was found to be 0.9708, indicating good fit. Among the independent variables selected and their interactions, only X 1 was found to be significant (p < 0.05), indicating a major contributing effect of X 1 on t 50 with RC. The negative coefficients for independent variable X 1 indicate an unfavorable effect on t 50 with RC, while the positive coefficients for independent variables X 2 and X 3 indicate a favorable effect on t 50 with RC. The interactions between two variables X 1 X 2 indicate a favorable effect on t 50 with RC. The coefficient b 1 was the only coefficient found to be significant (p < 0.05); hence it was retained in the reduced model. The reduced model was tested in portions to determine whether the entire coefficient contributes significant information for the prediction of t 50 with RC. The results testing the model in portions are shown in Table III .
The critical value of F = 4.82 (p = 0.05) is again higher than the calculated value (F = 3.3841). It may be concluded that none of the interaction terms except b 1 contribute significantly to the prediction of t 50 with RC and the low coefficients for these terms in Eq. (2) indicate that these terms contribute the least to the prediction of t 50 with RC. Hence, these terms were omitted from the full model to obtain a reduced first-order binomial Eq. (5): t 50 (with RC) = 12.18 -4.99 X 1 (5) This implies that the main effect of the percentage of polymers (pectin-compritol ATO 888) in compression coating is significant, as it is evident from the high coefficient. The results of multiple linear regression analysis (reduced model) reveal that, on increasing the percentage of polymers (pectin-compritol ATO 888) in compression coating, a decrease in t 50 with RC is observed; the coefficient b 1 bears a negative sign. It was concluded that if at higher level of X 1 (pectin-compritol ATO 888: 100-0), time for 50 % of drug released compression coated tablets was decreased. Thus, it was concluded that compritol ATO 888 could control drug release from the compression coated tablets. It was concluded from Table II that at medium level of X 1 , 50 % drug was released in 8 to 14 h. From Eq. (4), it was found that coefficients for X 2 and X 3 were positive i.e. if the coat mass and compression force were increased, time for 50 % drug release increased. It was concluded that the coat mass and compression force can also control drug release from compression coated tablets. Y 24 (with RC) was found to be in the range of 65.0 to 
The value of R 2 from Eq. (6) was found to be 0.9727, indicating good fit. Among the independent variables selected and their interactions, only X 1 and X 1 2 were found to be significant (p < 0.05), indicating a major contributing effect of X 1 on Y 24 (with RC). The negative coefficients for independent variables X 2 and X 3 indicate an unfavorable effect on Y 24 (with RC), but the value of coefficient of X 2 was much lower than X 3 , so X 3 alone has a major but unfavorable effect on Y 24 . The interactions between variables X 1 X 3 indicate a favorable effect on Y 24 (with RC). Coefficients b 1 and b 11 were found to be significant at p < 0.05; hence they were retained in the reduced model. The reduced model was tested in portions to determine whether the entire coefficient contributes significant information for the prediction of Y 24 with RC. The results of testing the model in portions are shown in Table III .
The calculated value (F = 4.31) was lower than the critical value (F = 4.88), leading to the conclusion that none of the interaction terms except b 1 and b 11 contribute significantly to the prediction of Y 24 with RC. Hence, these terms were omitted from the full model to obtain a reduced second-order polynomial Eq. (7):
Y 24 (with RC) = 94.99 + 14.76 X 1 -9.90 X 1 X 1 (7) This implies that the main effect of the percentage of polymers (pectin-compritol ATO 888) in compression coating is significant, as it is evident from the high coefficients. The results of multiple linear regression analysis (reduced model) reveal that, on increasing the percentage of polymers (pectin-compritol ATO 888) in compression coating, an increase in Y 24 (with RC) is observed; the coefficient b 1 bears a positive sign. It was concluded that at higher level of X 1 (pectin-compritol ATO 888: 100-0), 100 % of drug was released from compression coated tablet within 24 h. From Table II it was concluded that at low level of X 1 , 100 % drug was not released in 24 h. From Eq. (6) it was found that coefficients for X 2 and X 3 were negative, i.e., if coat mass and compression force were increased, drug release was decreased. From Table II it was concluded that medium level of X 1 (pectin-compritol ATO 888: 80-20) was selected for targeting compression coated tablets into colon without releasing the drug in the stomach and intestine. It was also concluded that compression force can also affect drug release during its transit from mouth to colon but not coat mass. Medium level of compression force was selected (formulations 13-15) because around 100 % drug was released in 24 h.
The relationship between the dependent and independent variables was further elucidated by constructing contour plots. The effects of X 1 and X 3 with their interactions on Y 5 at a fixed level of X 2 (medium level) are shown in Fig. 1 .
The plots were found to be nonlinear, indicating a nonlinear relationship between X 1 and X 3 . It was determined from the contour plot that a lower value of Y 5 (0 %) could be obtained with an X 1 level range from -0.1 to 0.0 and an X 3 level range from 0.0 to 1.0. It is evident from the contour that the low level of both X 1 and X 3 favors Y 5 . When the coefficient values of the two key variables, X 1 and X 3 , were compared, the value of variable X 1 (b 1 = 10.66) was found to be higher, indicating that it contributed the most to predicting the Y 5 . The negative effects of X 3 on Y 5 may be attributed to the coating force of compression coated tablets and it was concluded that at higher coating force, core tablets remain intact up to 5 h. Fig. 2 shows the contour plot drawn at a 0 level of X 3 . The contours of all Y 5 values were found to be curvilinear and indicated that a low value of Y 5 (0 %) can be obtained for a combination of the two independent variables, the X 1 level in the range of -1.0 to -0.3, and the X 2 level in the range of 0.0 to 1.0. The effects of X 1 and X 3 with their interaction on Y 24 at a fixed level of X 2 (medium level) are shown in Fig. 3 . The plots were found to be nonlinear, indicating a nonlinear relationship between X 1 and X 3 . It was determined from the contour plot that a higher value of Y 24 (100 %) could be obtained with an X 1 level range from 0.0 to 1.0 and an X 3 level range from -1.0 to 0.0. It is evident from the contour that the medium level of both X 1 and X 3 favors Y 24 .
The effects of X 1 and X 2 with their interaction on Y 24 at a fixed level of X 3 (medium level) are shown in Fig. 4 . The plots were found to be nonlinear indicating a nonlinear relationship between X 1 and X 2 . It was determined from the contour plot that a higher value of Y 24 (100 %) could be obtained with an X 1 level of 1.0 and an X 2 level range from -1.0 to 0.0. It is evident from the contour that the medium level of both X 1 and X 2 favors Y 24 . The effects of X 2 and X 3 with their interaction on Y 24 at a fixed level of X 1 (medium level) are shown in Fig. 5 . From Figures 1-5 , the following observations can be made. All contour plots for a high value of Y 5 and Y 24 were found to be nonlinear. This signifies that there is no direct linear relationship between the selected independent variables. A low value of Y 5 can be obtained for low and medium levels of X 1 but the low level of X 1 does not favor Y 24 . Thus, medium level of X 1 was selected. Similarly, at higher level of X 3 , the drug was not released up to 24 h, so the medium level of X 3 was selected. 
Checkpoint analysis
Three checkpoint batches were prepared and evaluated for Y 24 , as shown in Table V 
Optimum formula
After studying the effect of the independent variables on the responses, the levels of variables that give the optimum response were determined. It is evident from the polynomial equation and contour plots (Figs. 4 and 5 ) that a high level of X 1 could not target the compressed tablet to the colon and a low level of X 1 could not release the drug in 24 h. Hence, the medium level was selected as optimum for X 1 , since up to this level a low value of Y 5 (0 %) can be obtained. The optimum formulation is one that targets compressed tablets to the colon (Y 5 = 0 %), 50 % of the drug releases within 8 h after reaching the colon (t 50 with RC = 11 h) and the total amount of drug releases within 24 h in a controlled manner, Y 24 (with RC) = 100 %. Using a computer optimization process and the contour plot shown in Fig. 8 , we selected levels of 0.2 and -0.15 for both X 2 and X 3, respectively, which give the theoretical values of 0 % and 100.47 % for Y 5 and Y 24 , respectively. Hence, a 0 level (80-20) for percentage of polymers (pectin-compritol ATO 888) in compression coating (X 1 ), a 0.2 level of coating mass (X 2 ), and a -0.15 level of coating force (X 3 ) were selected as optimal. To prove this, a fresh formulation was prepared at optimum levels of the independent variables, and the resultant colon targeted compressed tablets were evaluated for the responses. The observed values of Y 5 and Y 24 with RC were found to be 0.7 % and 99.99 %, respectively, which were in close agreement with the theoretical values.
CONCLUSIONS
Optimization of a colon targeted formulation is a complex process that requires a large number of variables and their interactions to be considered. The present study conclusively demonstrates the use fulness of a Box-Behnken design in optimization of colon targeted formulations. The derived polynomial equations and contour plots aid in predicting the values of selected independent variables for preparation of the optimum controlled release colon targeted formulation of mesalamine with desired properties. 
